Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for b7- antigen
Most Correlated Studies
- CD8+ T cells from OT-1 mice after exposure to PD-L1
- Colorectal cancer (HT29 & HCT116) and melanoma PES43 cells treated with Nivolumab, sPD-L1 or both
- Response to IL-12 and Type I IFN with or without TCR and CD28 T-lymphocyte stimulation
- Peripheral blood mononuclear cells of old and young adults treated with TLR4, TLR7/8 & RIGI agonists
- CD4+ T cells of RAG2-null 5C.C7 mice with or without CTLA4 after adoptive transfer and immunization
Most Relevant Literature
- An integrated pan-cancer assessment of prognosis, immune infiltration, and immunotherapy response fo…
- Analysis of the different subpeptidomes presented by the HLA class I molecules of the B7 supertype.
- Kinetic Changes in B7 Costimulatory Molecules and IRF4 Expression in Human Dendritic Cells during LP…
- ICP8-vhs- HSV-2 Vaccine Expressing B7 Costimulation Molecules Optimizes Safety and Efficacy against …
- The MHC-II antigen presentation machinery and B7 checkpoint ligands display distinctive patterns cor…
Most Relevant Clinical Trials
- Phase I Study of Autologous CAR T-Cells Targeting the B7-H3 Antigen in Recurrent Epithelial Ovarian
- B7-H3 Chimeric Antigen Receptor T Cells (B7-H3CART) in Recurrent Glioblastoma Multiforme
- TAA06 Injection in the Treatment of Patients With B7-H3-positive Relapsed/ Refractory Neuroblastoma
- Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc
- Pilot Study of B7-H3 CAR-T in Treating Patients With Recurrent and Refractory Glioblastoma
